Serial 99516292
Live / Allowed — Approved for publication (as of 01 Apr 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 25 Nov 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99516292
- Mark type
- Design / logo
- Filed
- 25 Nov 2025
- Attorney of record
- Karl M. Zielaznicki
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for use in the treatment of cancer and blood diseases and disorders
Owner
- Takeda Pharmaceuticals U.S.A., Inc., Cambridge, MA, US
Prosecution history
- 01 Apr 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Mar 2026 — ASSIGNED TO EXAMINER
- 26 Mar 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 26 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 15 Dec 2025 — TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
- 15 Dec 2025 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 25 Nov 2025 — APPLICATION FILING RECEIPT MAILED
- 25 Nov 2025 — NEW APPLICATION ENTERED